Charles E. Thirkill

3.3k total citations
65 papers, 2.2k citations indexed

About

Charles E. Thirkill is a scholar working on Neurology, Ophthalmology and Molecular Biology. According to data from OpenAlex, Charles E. Thirkill has authored 65 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Neurology, 37 papers in Ophthalmology and 21 papers in Molecular Biology. Recurrent topics in Charles E. Thirkill's work include Autoimmune Neurological Disorders and Treatments (35 papers), Drug-Induced Ocular Toxicity (20 papers) and Ocular Oncology and Treatments (19 papers). Charles E. Thirkill is often cited by papers focused on Autoimmune Neurological Disorders and Treatments (35 papers), Drug-Induced Ocular Toxicity (20 papers) and Ocular Oncology and Treatments (19 papers). Charles E. Thirkill collaborates with scholars based in United States, Germany and France. Charles E. Thirkill's co-authors include John L. Keltner, Alan M. Roth, Nancy K. Tyler, Stuart J. Tipping, Daniel M. Jacobson, Dale S. Gregerson, Robert C. Tait, Robert C. Sergott, Paul G. Fitzgerald and William M. Hart and has published in prestigious journals such as New England Journal of Medicine, The Journal of Immunology and Annals of Neurology.

In The Last Decade

Charles E. Thirkill

64 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles E. Thirkill United States 25 1.2k 1.1k 740 297 224 65 2.2k
Alan M. Roth United States 20 816 0.7× 421 0.4× 433 0.6× 72 0.2× 150 0.7× 52 1.5k
David McLeod United Kingdom 37 2.6k 2.2× 532 0.5× 1.0k 1.4× 85 0.3× 149 0.7× 117 3.7k
August F. Deutman Netherlands 36 2.9k 2.5× 258 0.2× 2.7k 3.7× 118 0.4× 229 1.0× 120 4.5k
A. Jacob United Kingdom 17 474 0.4× 663 0.6× 165 0.2× 121 0.4× 130 0.6× 37 1.6k
Ordan J. Lehmann Canada 29 810 0.7× 77 0.1× 1.5k 2.0× 145 0.5× 85 0.4× 56 2.6k
Kumaran Deiva France 27 82 0.1× 1.2k 1.1× 463 0.6× 259 0.9× 299 1.3× 97 2.4k
M. Söderström Sweden 29 373 0.3× 452 0.4× 275 0.4× 975 3.3× 137 0.6× 55 2.4k
Yu-Min Huang Sweden 27 129 0.1× 347 0.3× 517 0.7× 1.2k 4.0× 167 0.7× 80 2.5k
Toshiaki Kubota Japan 28 1.9k 1.6× 223 0.2× 518 0.7× 69 0.2× 81 0.4× 96 2.3k
Nasrin Asgari Denmark 25 240 0.2× 1.7k 1.6× 294 0.4× 371 1.2× 144 0.6× 83 2.8k

Countries citing papers authored by Charles E. Thirkill

Since Specialization
Citations

This map shows the geographic impact of Charles E. Thirkill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles E. Thirkill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles E. Thirkill more than expected).

Fields of papers citing papers by Charles E. Thirkill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles E. Thirkill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles E. Thirkill. The network helps show where Charles E. Thirkill may publish in the future.

Co-authorship network of co-authors of Charles E. Thirkill

This figure shows the co-authorship network connecting the top 25 collaborators of Charles E. Thirkill. A scholar is included among the top collaborators of Charles E. Thirkill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles E. Thirkill. Charles E. Thirkill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lima, Luiz H., Jonathan P. Greenberg, Vivienne C. Greenstein, et al.. (2012). HYPERAUTOFLUORESCENT RING IN AUTOIMMUNE RETINOPATHY. Retina. 32(7). 1385–1394. 45 indexed citations
2.
Lujan, Brandon J., et al.. (2011). Outer Retinal Structure in Patients With Acute Zonal Occult Outer Retinopathy. American Journal of Ophthalmology. 153(4). 757–768.e1. 39 indexed citations
3.
Bianciotto, Carlos, C.L. Shields, Charles E. Thirkill, Miguel A. Materin, & J. A. Shields. (2009). Paraneoplastic retinopathy with multiple detachments of the neurosensory retina and autoantibodies against interphotoreceptor retinoid binding protein (IRBP) in cutaneous melanoma. British Journal of Ophthalmology. 94(12). 1684–1685. 17 indexed citations
4.
Espandar, Ladan, et al.. (2007). Successful treatment of cancer-associated retinopathy with alemtuzumab. Journal of Neuro-Oncology. 83(3). 295–302. 33 indexed citations
5.
Parc, C., et al.. (2006). Cone Dysfunction as a Paraneoplastic Syndrome Associated with Retinal Antigens Approximating 40 kiloDalton. Ophthalmic Genetics. 27(2). 57–61. 16 indexed citations
6.
Ladewig, Gesa, Uwe Reinhold, Charles E. Thirkill, et al.. (2005). Incidence of antiretinal antibodies in melanoma: screening of 77 serum samples from 51 patients with American Joint Committee on Cancer stage I-IV. British Journal of Dermatology. 152(5). 931–938. 26 indexed citations
7.
Schuster, Andreas, Eckart Apfelstedt-Sylla, Carsten M. Pusch, Eberhart Zrenner, & Charles E. Thirkill. (2005). Autoimmune Retinopathy with RPE Hypersensitivity and ‘Negative ERG’ in X-Linked Hyper-IgM Syndrome. Ocular Immunology and Inflammation. 13(2-3). 235–243. 16 indexed citations
8.
Thirkill, Charles E., et al.. (2004). The incidence of ‘normal antibody activity’ with retinain a population of 100 normal individuals. Investigative Ophthalmology & Visual Science. 45(13). 547–547. 1 indexed citations
9.
Pföhler, Claudia, Anja Palmowski-Wolfe, Selma Ugurel, et al.. (2003). Melanoma-associated retinopathy: high frequency of subclinical findings in patients with melanoma. British Journal of Dermatology. 149(1). 74–78. 26 indexed citations
10.
Palmowski-Wolfe, Anja, Claudia Pföhler, Uwe Reinhold, et al.. (2002). Melanoma-associated retinopathy: screening for melanoma-associated retinopathy in patients with cutaneous malignant melanoma. Neuro-Ophthalmology. 27(1-3). 121–137. 8 indexed citations
11.
12.
Thirkill, Charles E., et al.. (2002). Lymphoma-associated retinopathy. Ophthalmology. 109(11). 2149–2153. 28 indexed citations
13.
Keltner, John L., et al.. (2001). Clinical and Immunologic Characteristics of Melanoma-Associated Retinopathy Syndrome: Eleven New Cases and a Review of 51 Previously Published Cases. Journal of Neuro-Ophthalmology. 21(3). 173–187. 168 indexed citations
14.
15.
Thirkill, Charles E.. (1997). Experimental, cancer-induced retinopathy. Ocular Immunology and Inflammation. 5(1). 55–66. 16 indexed citations
16.
Kimura, Alan, et al.. (1997). Autoimmune Retinopathy in the Absence of Cancer. American Journal of Ophthalmology. 123(5). 607–618. 75 indexed citations
17.
Thirkill, Charles E.. (1994). Cancer associated retinopathy. Neuro-Ophthalmology. 14(5). 297–323. 12 indexed citations
18.
Thirkill, Charles E., Robert C. Tait, Nancy K. Tyler, Alan M. Roth, & John L. Keltner. (1992). The cancer-associated retinopathy antigen is a recoverin-like protein.. PubMed. 33(10). 2768–72. 159 indexed citations
19.
Jacobson, Daniel M., Charles E. Thirkill, & Stuart J. Tipping. (1990). A clinical triad to diagnose paraneoplastic retinopathy. Annals of Neurology. 28(2). 162–167. 145 indexed citations
20.
Thirkill, Charles E., Paul G. Fitzgerald, Robert C. Sergott, et al.. (1989). Cancer-Associated Retinopathy (CAR Syndrome) with Antibodies Reacting with Retinal, Optic-Nerve, and Cancer Cells. New England Journal of Medicine. 321(23). 1589–1594. 183 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alan M. Roth Breakdown of academic impact, for papers by David McLeod Breakdown of academic impact, for papers by August F. Deutman Breakdown of academic impact, for papers by A. Jacob Breakdown of academic impact, for papers by Ordan J. Lehmann Breakdown of academic impact, for papers by Kumaran Deiva Breakdown of academic impact, for papers by M. Söderström Breakdown of academic impact, for papers by Yu-Min Huang Breakdown of academic impact, for papers by Toshiaki Kubota Breakdown of academic impact, for papers by Nasrin Asgari
Rankless by CCL
2026